Home›Pediatrics› PM2.0 Framework Proposes Evidence-Calibrated Integration in Periodontal Medicine
PM2.0 Framework Proposes Evidence-Calibrated Integration in Periodontal MedicineNew framework aims to improve care for periodontal disease
Frontiers in MedicinePublished October 10, 2026Study authors: Marde Shraddha Kashinath, Geeta Mandavilli, Prathyusha ChavaDOI ↗Editorial oversight: Dr. Sofia Müller, MD · Lifespan & Whole-Person Care
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Interpret PM2.0 as a hypothesis, not a validated model or guideline.
This publication presents Periodontal Medicine 2.0 (PM2.0), described as a conceptual hypothesis and guideline-type framework for periodontal patients. It is not a clinical guideline, not an established historical stage, and not a validated model of care, as the authors explicitly state.
The framework proposes that appropriately connected and evidence-calibrated functions may generate greater translational value than fragmented approaches. It distinguishes association from causality and positions itself as a move from association to evidence-based action in periodontal medicine.
Secondary outcomes proposed for evaluation include clinical, patient reported, implementation, economic, safety, and equity outcomes. No primary outcome, sample size, setting, follow-up, or effect estimates are reported. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, are not reported.
Limitations acknowledged by the authors are that PM2.0 is not an established historical stage, not a clinical guideline, and not a validated model of care. Funding and conflicts of interest are not reported.
Practice relevance is framed as a proposal for evidence-calibrated, integrated, and patient-centred care in periodontal medicine. Clinicians should interpret this as a hypothesis-generating framework rather than an actionable protocol.
How this fits prior evidence
Prior coverage has documented observational associations between periodontal disease and systemic conditions, including a 2.67 odds ratio for Alzheimer's disease, increased pancreatic cancer risk, increased oral cancer odds, and a 3.6 times higher odds of frailty in older adults with fewer than 20 teeth. Those findings were consistently framed as associations, not causation. The PM2.0 framework extends this theme by explicitly distinguishing association from causality and proposing evidence-calibrated integration. It does not confirm or contrast any specific prior association; instead it addresses a gap by arguing for a structured, patient-centred approach to translating observational signals into evidence-based action.
Managing gum disease, or periodontal disease, can often feel like a fragmented process. A new conceptual framework called Periodontal Medicine 2.0 aims to change that. Instead of using disconnected methods, this approach suggests that connecting and calibrating different functions based on solid evidence can lead to better results for patients.
This framework focuses on moving from just identifying associations to taking evidence-based actions. It looks at several areas of success, including clinical outcomes, patient reported outcomes, and economic and equity outcomes. By integrating these pieces, the goal is to create a more centered way of caring for those with gum disease.
It is important to note that this is currently a literature-informed hypothesis. It is not a validated model of care or an established clinical guideline yet. While it offers a new way to think about integrated care, it is still in the early stages of development as a concept.
What this means for you:
A new proposed framework aims to improve gum disease care by connecting evidence-based actions with patient needs.
Common questions
What is Periodontal Medicine 2.0?
Periodontal Medicine 2.0 is a proposed framework for gum disease care. It aims to move away from fragmented approaches and toward a system where functions are connected and calibrated by evidence. The goal is to provide more integrated and patient-centered care for people with periodontal disease.
Is this a proven treatment for gum disease?
No, this is not a validated model of care or an established clinical guideline. It is currently a literature-informed hypothesis. It is designed to suggest a better way to organize care, but it has not been proven as a standard clinical practice yet.
What outcomes does this framework consider?
The framework looks at several different types of outcomes to improve care. These include clinical outcomes, patient reported outcomes, and implementation outcomes. It also considers economic outcomes, safety outcomes, and equity outcomes to ensure a more complete approach to treatment.
Periodontal medicine has generated substantial evidence that periodontal and systemic health are biologically, behaviourally, and socially interconnected. Yet a persistent translational gap remains: knowledge of oral-systemic relationships has advanced faster than the systems required to convert this knowledge into coordinated, patient-centred care. Dentistry and medicine continue to operate within fragmented professional structures, limiting opportunities for prevention, early risk identification, and longitudinal disease management. We propose Periodontal Medicine 2.0 (PM2.0), an author derived conceptual hypothesis that reimagines periodontal medicine beyond the study of oral-systemic associations toward evidence-calibrated translation and integrated care. Its proposed contribution lies in the clinically significant interactions amongst the four principal domains centred on the periodontal patient: integrated oral-systemic screening, interprofessional collaborative care, precision periodontal medicine, and population health and policy integration. Digital health and AI, patient engagement, health literacy, equity, ethics and implementation science are positioned as cross-cutting enablers. PM2.0 proposes that these domains should interact according to evidence maturity, clinical relevance and implementation readiness, rather than through uniform integration. The framework distinguishes association from causality, screening from diagnosis, diagnostic performance from clinical utility, and technological capability from demonstrated patient benefit. It proposes a risk based, longitudinal pathway linking periodontal assessment with selective risk identification, coordinated care, individualized management and evaluation. The central hypothesis is that appropriately connected and evidence-calibrated functions may generate greater translational value than fragmented approaches. This proposition is testable through clinical, patient reported, implementation, economic, safety and equity outcomes. PM2.0 is therefore presented not as an established historical stage, clinical guideline or validated model of care, but as a literature-informed hypothesis for the future organization of periodontal medicine- from association to evidence based action, and from action to demonstrable impact.
